Integrin β3 Leu33Pro polymorphism and breast cancer risk: A population-based case-control study in Germany

Breast Cancer Research and Treatment

Volumn 88, Issue 3, 2004, Pages 231-237

  Wang Gohrke, Shan ^a   Chang Claude, Jenny ^b  

^a UNIVERSITY OF ULM   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Breast cancer; Integrin 3; Metastasis; Polymorphism; Population based case control study

Indexed keywords

BETA3 INTEGRIN; LEUCINE; PROLINE;

ADULT; AGE DISTRIBUTION; ALLELE; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER GRADING; CANCER RISK; CAUCASIAN; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE CARRIER; FEMALE; GENETIC POLYMORPHISM; GERMANY; HOMOZYGOSITY; HUMAN; INHERITANCE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RISK ASSESSMENT; STATISTICAL SIGNIFICANCE; TUMOR VOLUME; WILD TYPE; AGE; BREAST TUMOR; CASE CONTROL STUDY; GENETICS; MIDDLE AGED; PAGET NIPPLE DISEASE; RISK; RISK FACTOR;

ADULT; AGE FACTORS; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CASE-CONTROL STUDIES; FEMALE; GERMANY; HUMANS; INTEGRIN BETA3; MIDDLE AGED; ODDS RATIO; POLYMORPHISM, GENETIC; RISK FACTORS;

EID: 12344328441     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10549-004-0782-5     Document Type: Article

References (16)

1. Tucker GC: Inhibitors of integrins. Curr Opin Pharmacol 2: 394-402, 2002
2. Mizejewski GJ: Role of integrins in cancer: survey of expression patterns. Proc Soc Exp Biol Med 222: 124-138, 1999
3. Hood JD, Cheresh DA: Role of integrins in cell invasion and migration. Nat Rev Cancer 2: 91-100, 2002
4. Felding-Habermann B, O'Toole TE, Smith JW, Fransvea E, Ruggeri ZM, Ginsberg MH, Hughes PE, Pampori N, Shattil SJ, Saven A, Mueller BM: Integrin activation controls metastasis in human breast cancer. Proc Natl Acad Sci USA 98: 1853-1858, 2001
5. Bussel JB, Kunicki TJ, Michelson AD: Platelets: new understanding of platelet glycoproteins and their role in disease. Hematology (Am Soc Hematol Educ Program): 222-240, 2000
6. Ayala F, Corral J, Gonzalez-Conejero R, Sanchez I, Moraleda JM, Vicente V: Genetic polymorphisms of platelet adhesive molecules: association with breast cancer risk and clinical presentation. Breast Cancer Res Treat 80(2): 145-154, 2003
7. Bojesen SE, Tybjaerg-Hansen A, Nordestgaard BG: Integrin beta3 Leu33Pro homozygosity and risk of cancer. J Natl Cancer Inst 95(15): 1150-1157, 2003
8. Jin Q, Hemminki K, Grzybowska E, Klaes R, Soderberg M, Forsti A: Re: Integrin beta3 Leu33Pro homozygosity and risk of cancer [letter]. J Natl Cancer Inst 96(3): 234-235, 2004
9. Bennett JS, Catella-Lawson F, Rut AR, Vilaire G, Qi W, Kapoor SC, Murphy S, FitzGerald GA: Effect of the Pl(A2) alloantigen on the function of beta(3)-integrins in platelets. Blood 97: 3093-3099, 2001
10. Andrioli G, Minuz P, Solero P, Pincelli S, Ortolani R, Lussignoli S, Bellavite P: Defective platelet response to arachidonic acid and thromboxane A(2) in subjects with PlA2 polymorphism of beta(3) subunit (glycoprotein IIIa). Br J Haematol 110: 911-918, 2000
11. Michelson AD, Furman MI, Goldschmidt-Clermont P, Mascelli MA, Hendrix C, Coleman L, Hamlington J, Barnard MR, Kickler T, Christie DJ, Kundu S, Bray PF: Platelet GP IIIa PlA polymorphisms display different sensitivities to agonists. Circulation 101: 1013-1018, 2000
12. Szczeklik A, Undas A, Sanak M, Frolow M, Wegrzyn W: Relationship between bleeding time, aspirin and the PlA1/A2 polymorphism of platelet glycoprotein IIIa. Br J Haematol 110: 965-967, 2000
13. Undas A, Brummel K, Musial J, Mann KG, Szczeklik A: Pl(A2) polymorphism of beta(3) integrins is associated with enhanced thrombin generation and impaired antithrombotic action of aspirin at the site of microvascular injury. Circulation 104: 2666-2672, 2001
14. Feng D, Lindpaintner K, Larson MG, Rao VS, O'Donnell CJ, Lipinska I, Schmitz C, Sutherland PA, Silbershatz H, D'Agostino RB, Muller JE, Myers RH, Levy D, Tofler GH: Increased platelet aggregability associated with platelet GPIIIa PlA2 polymorphism: the Framingham Offspring Study. Arterioscler Thromb Vasc Biol 19: 1142-1147, 1999
15. Vijayan KV, Liu Y, Dong JF, Bray PF: Enhanced activation of mitogenactivated protein kinase and myosin light chain kinase by the Pro33 polymorphism of integrin beta 3. J Biol Chem 278: 3860-3867, 2003
16. Chang-Claude J, Eby N, Kiechle M, Bastert G, Becher H: Breastfeeding and breast cancer risk by age 50 among women in Germany. Cancer Causes Control 11(8): 687-695, 2000